documents: FDA-2019-D-4751-0013
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-D-4751-0013 | FDA | FDA-2019-D-4751 | FDA Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs; Guidance for Industry; Availability | Notice | Notice of Availability | 2021-05-25T04:00:00Z | 2021 | 5 | 2021-05-25T04:00:00Z | 2021-05-25T12:41:42Z | 2021-11022 | 0 | 0 | 0900006484b333db |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref